7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
Evidence-based guide to amlodipine dosing in Black and African ancestry patients, including pharmacogenomic considerations, trial data from ALLHAT and ASCOT-BPLA, and clinical recommendations for optimizing blood pressure control.
East Asian patients may need lower starting doses of amlodipine due to CYP3A5 polymorphisms, slower clearance, and higher plasma exposure. This guide covers the pharmacogenomic evidence, dosing recommendations, and clinical considerations for East Asian populations.
How does amlodipine behave differently in Hispanic and Latino patients? This evidence-based guide covers pharmacogenomics, CYP3A5 variants, ethnicity-stratified trial data, dosing considerations, and diabetes-related safety signals specific to Hispanic and Latino populations.
Evidence-based review of amlodipine efficacy in Black and African ancestry patients, including ALLHAT and ASCOT-BPLA trial data, pharmacogenomic considerations, and guideline-directed dosing.
A practical guide to amlodipine prescribing that avoids unsupported race-based dose rules and focuses on the current label, response, and adverse-effect monitoring.
A comprehensive clinical review of amlodipine efficacy differences in Hispanic and Latino patients, covering pharmacogenomics, CYP3A4/5 variants, ethnicity-stratified trial data, and dosing considerations for this population.
Do South Asian patients need different amlodipine doses? This clinically detailed guide covers pharmacogenomics, ethnicity-stratified trial data, and practical dosing guidance for South Asian adults with hypertension.